GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nippon Shinyaku Co Ltd (OTCPK:NPPNY) » Definitions » EV-to-Revenue

NPPNY (Nippon Shinyaku Co) EV-to-Revenue : 1.35 (As of Dec. 12, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Nippon Shinyaku Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Nippon Shinyaku Co's enterprise value is $1,403 Mil. Nippon Shinyaku Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was $1,040 Mil. Therefore, Nippon Shinyaku Co's EV-to-Revenue for today is 1.35.

The historical rank and industry rank for Nippon Shinyaku Co's EV-to-Revenue or its related term are showing as below:

NPPNY' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.95   Med: 3.74   Max: 5.63
Current: 1.43

During the past 13 years, the highest EV-to-Revenue of Nippon Shinyaku Co was 5.63. The lowest was 0.95. And the median was 3.74.

NPPNY's EV-to-Revenue is ranked better than
71.03% of 994 companies
in the Drug Manufacturers industry
Industry Median: 2.48 vs NPPNY: 1.43

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-12-12), Nippon Shinyaku Co's stock price is $6.75. Nippon Shinyaku Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $3.86. Therefore, Nippon Shinyaku Co's PS Ratio for today is 1.75.


Nippon Shinyaku Co EV-to-Revenue Historical Data

The historical data trend for Nippon Shinyaku Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nippon Shinyaku Co EV-to-Revenue Chart

Nippon Shinyaku Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.52 4.08 3.62 2.25 1.59

Nippon Shinyaku Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.43 1.86 1.59 1.46 1.22

Competitive Comparison of Nippon Shinyaku Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Nippon Shinyaku Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nippon Shinyaku Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nippon Shinyaku Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nippon Shinyaku Co's EV-to-Revenue falls into.



Nippon Shinyaku Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Nippon Shinyaku Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1402.710/1039.97
=1.35

Nippon Shinyaku Co's current Enterprise Value is $1,403 Mil.
Nippon Shinyaku Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,040 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nippon Shinyaku Co  (OTCPK:NPPNY) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Nippon Shinyaku Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=6.75/3.86
=1.75

Nippon Shinyaku Co's share price for today is $6.75.
Nippon Shinyaku Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.86.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nippon Shinyaku Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nippon Shinyaku Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Nippon Shinyaku Co Business Description

Traded in Other Exchanges
Address
14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto, JPN, 601-8550
Nippon Shinyaku Co Ltd is a specialty and generic drug manufacturing company. Nippon's research and development activities include a focus on pharmaceuticals, nutraceuticals, safety and pharmacokinetics of drug seeds, genomic drug discovery, and nucleic acid drugs. The company also develops health food ingredients, preservatives, protein preparations, and spices. Nippon considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Nippon Shinyaku Co Headlines

No Headlines